![Sunil Kadam](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sunil Kadam
General Counsel bei
Takeda California, Inc.
Health Technology
Profil
Sunil Kadam is currently the Head of Regulatory Affairs at Takeda California, Inc. He was previously the Senior Vice President of Global Regulatory Affairs at Madrigal Pharmaceuticals, Inc. in 2022 and held the same position at Telix Pharmaceuticals Ltd.
Aktive Positionen von Sunil Kadam
| Unternehmen | Position | Beginn |
|---|---|---|
Takeda California, Inc.
 Takeda California, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | General Counsel | - |
Ehemalige bekannte Positionen von Sunil Kadam
| Unternehmen | Position | Ende |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | General Counsel | 01.02.2022 |
| MADRIGAL PHARMACEUTICALS, INC. | General Counsel | 08.01.2022 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Takeda California, Inc.
Takeda California, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Madrigal Pharmaceuticals, Inc.
 Madrigal Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs for cardiovascular, metabolic and liver diseases | Health Technology |
Telix Pharmaceuticals Ltd.
 Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
Wählen Sie MarketScreener 
